Are you Dr. Zhao?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 15 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
940 Stanton L. Young Blvd
Bms - 451
Oklahoma City, OK 73104Phone+1 405-271-1515Fax+1 405-271-1001
Summary
- Dr. Lichao Zhao, MD is a board certified pathologist in Oklahoma City, Oklahoma. He is currently licensed to practice medicine in Oklahoma. He is affiliated with Oklahoma City VA Medical Center and OU Medical Center Edmond.
Education & Training
- University of Texas M D Anderson Cancer CenterFellowship, Cytopathology, 2010 - 2011
- University of Oklahoma Health Sciences CenterResidency, Pathology-Anatomic and Clinical, 2006 - 2010
- Tianjin Medical UniversityClass of 1991
Certifications & Licensure
- OK State Medical License 2008 - 2025
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Cytopathology
Publications & Presentations
PubMed
- 44 citationsDoublecortin-Like Kinase 1 Is Elevated Serologically in Pancreatic Ductal Adenocarcinoma and Widely Expressed on Circulating Tumor CellsDongfeng Qu, Jeremy J. Johnson, Parthasarathy Chandrakesan, Nathaniel Weygant, Randal May
Plos One. 2015-02-27 - 83 citationsDCLK1 is a broadly dysregulated target against epithelial-mesenchymal transition, focal adhesion, and stemness in clear cell renal carcinomaNathaniel Weygant, Dongfeng Qu, Randal May, Ryan M. Tierney, William L. Berry
Oncotarget. 2015-01-10 - 53 citationsAlternative splice variants of DCLK1 mark cancer stem cells, promote self‐renewal and drug‐resistance, and can be targeted to inhibit tumorigenesis in kidney cancerYang Ge, Nathaniel Weygant, Dongfeng Qu, Randal May, William L. Berry
International Journal of Cancer. 2018-09-01